Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Hickman

Showing results (421-430 of 519) with videos related to

Pageof 52
Sort By:
International Journal of Epidemiology|December 28, 2021
Cohort Profile: The Melbourne Injecting Drug User Cohort Study (SuperMIX)Wijnand Van Den Boom, Maria Del Mar Quiroga, Daniel O'Keefe, et al.
Journal of Viral Hepatitis|August 9, 2019
Modelling the potential prevention benefits of a treat-all hepatitis C treatment strategy at global, regional and country levels: A modelling studyAdam Trickey, Hannah Fraser, Aaron G Lim, et al.
BMC Public Health|November 24, 2022
Exploring the impact of shielding advice on the wellbeing of individuals identified as clinically extremely vulnerable amid the COVID-19 pandemic: a mixed-methods evaluationGemma Lasseter, Polly Compston, Charlotte Robin, et al.
The International Journal on Drug Policy|January 16, 2026
Initiation, cessation and resumption of attendance at the Melbourne supervised injecting room among a cohort of people who inject drugsAshleigh C Stewart, Kasun Rathnayake, Adelina Artenie, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|September 18, 2014
Evaluating the role of a galanin enhancer genotype on a range of metabolic, depressive and addictive phenotypesTom G Richardson, Camelia Minica, Jon Heron, et al.
The Lancet. Global Health|October 28, 2017
Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic reviewLouisa Degenhardt, Amy Peacock, Samantha Colledge, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 25, 2020
Association Between Opioid Agonist Therapy and Testing, Treatment Uptake, and Treatment Outcomes for Hepatitis C Infection Among People Who Inject Drugs: A Systematic Review and Meta-analysisJason Grebely, Lucy Tran, Louisa Degenhardt, et al.
The Cochrane Database of Systematic Reviews|September 26, 2017
Personalised digital interventions for reducing hazardous and harmful alcohol consumption in community-dwelling populationsEileen Fs Kaner, Fiona R Beyer, Claire Garnett, et al.
The International Journal on Drug Policy|May 30, 2026
Can real-world scaling up HCV treatment in people who inject drugs be cost-saving: an economic modelling study in the UKZoe Ward, Hannah Fraser, Stuart Mc Pherson, et al.
Addiction (Abingdon, England)|March 2, 2021
Reduction in the population prevalence of hepatitis C virus viraemia among people who inject drugs associated with scale-up of direct-acting anti-viral therapy in community drug services: real-world dataNorah E Palmateer, Andrew McAuley, John F Dillon, et al.
Pageof 52

Showing results (421-430 of 519) with videos related to

Sort By:
Pageof 52
International Journal of Epidemiology|December 28, 2021
Cohort Profile: The Melbourne Injecting Drug User Cohort Study (SuperMIX)Wijnand Van Den Boom, Maria Del Mar Quiroga, Daniel O'Keefe, et al.
Journal of Viral Hepatitis|August 9, 2019
Modelling the potential prevention benefits of a treat-all hepatitis C treatment strategy at global, regional and country levels: A modelling studyAdam Trickey, Hannah Fraser, Aaron G Lim, et al.
BMC Public Health|November 24, 2022
Exploring the impact of shielding advice on the wellbeing of individuals identified as clinically extremely vulnerable amid the COVID-19 pandemic: a mixed-methods evaluationGemma Lasseter, Polly Compston, Charlotte Robin, et al.
The International Journal on Drug Policy|January 16, 2026
Initiation, cessation and resumption of attendance at the Melbourne supervised injecting room among a cohort of people who inject drugsAshleigh C Stewart, Kasun Rathnayake, Adelina Artenie, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|September 18, 2014
Evaluating the role of a galanin enhancer genotype on a range of metabolic, depressive and addictive phenotypesTom G Richardson, Camelia Minica, Jon Heron, et al.
The Lancet. Global Health|October 28, 2017
Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic reviewLouisa Degenhardt, Amy Peacock, Samantha Colledge, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 25, 2020
Association Between Opioid Agonist Therapy and Testing, Treatment Uptake, and Treatment Outcomes for Hepatitis C Infection Among People Who Inject Drugs: A Systematic Review and Meta-analysisJason Grebely, Lucy Tran, Louisa Degenhardt, et al.
The Cochrane Database of Systematic Reviews|September 26, 2017
Personalised digital interventions for reducing hazardous and harmful alcohol consumption in community-dwelling populationsEileen Fs Kaner, Fiona R Beyer, Claire Garnett, et al.
The International Journal on Drug Policy|May 30, 2026
Can real-world scaling up HCV treatment in people who inject drugs be cost-saving: an economic modelling study in the UKZoe Ward, Hannah Fraser, Stuart Mc Pherson, et al.
Addiction (Abingdon, England)|March 2, 2021
Reduction in the population prevalence of hepatitis C virus viraemia among people who inject drugs associated with scale-up of direct-acting anti-viral therapy in community drug services: real-world dataNorah E Palmateer, Andrew McAuley, John F Dillon, et al.
Pageof 52